| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/12/2007 | EP0842268B1 Methods and compositions for identifying morphogen analogs |
| 09/12/2007 | EP0776161B2 Use of a viral vector encoding a cytochrome p450 gene in combination with a chemotherapeutic agent for selectively destroying neoplastic cells |
| 09/12/2007 | EP0651807B1 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents |
| 09/12/2007 | CN101036055A Detection of elevated levels of Her-2/neu protein on circulating cancer cells and treatment |
| 09/12/2007 | CN101035891A Lecithinized superoxide dismutase composition and process for producing the same |
| 09/12/2007 | CN101035806A Amylin family polypeptide-6 (AFP-6) analogs and methods of making and using them |
| 09/12/2007 | CN101035805A Deglycosylated and desialidated long pentraxin PTX3 |
| 09/12/2007 | CN101035802A Inhibitors of IAP |
| 09/12/2007 | CN101035557A A pharmaceutical formulation comprising crystalline insulin and dissolved insulin |
| 09/12/2007 | CN101035556A Use of organic compounds |
| 09/12/2007 | CN101035555A Combination anti-viral compositions comprising castanospermine and methods of use |
| 09/12/2007 | CN101035554A Peptide inhibitors for mediating stress responses |
| 09/12/2007 | CN101035547A Use of compounds containing thiol groups as an efflux pump inhibitor |
| 09/12/2007 | CN101035545A Pulmonary administration of an antithrombotic compound |
| 09/12/2007 | CN101035513A Tissue enhancement implant and method |
| 09/12/2007 | CN101033255A Fusion protein of P11 and SAK and its preparation method and use |
| 09/12/2007 | CN101033253A Recombination Japanese lamprey oral gland Grimin protein induction cell apoptosis and its antineoplastic action |
| 09/12/2007 | CN101033250A Peptide arginals and methods for treating disseminated intravascular coagulation |
| 09/12/2007 | CN101032623A Targeting chitosan carrier guided by folic acid receptor and the preparing method and the application |
| 09/12/2007 | CN101032620A Cyclosporine emulsion and the preparing method |
| 09/12/2007 | CN101032532A Medicine composition including active substrates extracted from Sang Huang, the preparing method and the application in the producing of medicine thereof |
| 09/12/2007 | CN100336907C Recombinant human platelet auxin/dry cell factor fusion protein and preparation thereof |
| 09/12/2007 | CN100336903C Extracting norfibroase from snake venom and preparation process for liquid drugs injection of norfibroase |
| 09/12/2007 | CN100336827C South China sea conus littertus linnaeus nervotoxin and its coding sequence and use |
| 09/12/2007 | CN100336825C Renaturation of reconstituted human bone protein-1 and making method of its preparation |
| 09/12/2007 | CN100336557C Somatostation a aqua prepn and its prepn process and application |
| 09/11/2007 | US7268227 Posh nucleic acids, polypeptides and related methods |
| 09/11/2007 | US7268224 Human glucocorticoid receptor 1A promoter and splice variants |
| 09/11/2007 | US7268223 An antagonists, or agonists, producing antibodies, used as immunotherapy treating allergy, acquired immune deficiency syndrome, autoimmune diabetes, thyroiditis |
| 09/11/2007 | US7268219 May be used to promote lysis of the target cell by T cells in the immune system or to promote proliferation of specific T cell clones |
| 09/11/2007 | US7268214 peptidomimetics; enhanced uptake via gastrointestinal systems |
| 09/11/2007 | US7268213 Glucagon-like peptide-1 (glp-1) receptor agonist |
| 09/11/2007 | US7268210 PEG-LHRH analog conjugates |
| 09/11/2007 | US7268209 Peptides, derivates thereof, process for producing the same, novel strain producing the same, and antiviral agent comprising the same as active ingredient |
| 09/11/2007 | US7268208 Solubility in aqueous solvents; for use in diagnosis, therapy |
| 09/11/2007 | US7268207 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 09/11/2007 | US7268164 Administering an amino carbonyl compound |
| 09/11/2007 | US7268155 Photosensitizer conjugates for pathogen targeting |
| 09/11/2007 | US7268121 Suppression of nuclear factor-κB dependent processes using oligonucleotides |
| 09/11/2007 | US7268120 Administering into a muscle of a mammal with cancer or metastasis thereof, a DNA plasmid comprising a polynucleotide which encodes interferon-alpha or an active fragment thereof, operably associated with a promoter |
| 09/11/2007 | US7268118 Thymosin β4 compositions |
| 09/11/2007 | US7268117 Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis |
| 09/11/2007 | US7268116 Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins |
| 09/11/2007 | US7268115 Cyclic peptides; three-dimensional structures; screening; anticancer agents; angiogenesis inhibitors; drug delivery |
| 09/11/2007 | US7268114 Protein and process for preparing the same |
| 09/11/2007 | US7268113 Administering dosage complexed to blood |
| 09/11/2007 | US7268112 Prophylaxis of bone disorders comprising administering insulin and derivatives, and optionally in combination with peptide growth factors, metabolic antagonist, osteoprotegerins, synovial or antiinflammatory agents, in sustained release form |
| 09/11/2007 | US7268111 A carbamate or urea containing comopound is useful to treat angiogeneisis; methionine aminopeptidase 2 (MetAP-2) coupled to a peptide prevents the metabolic degradation of the angiogenesis inhibitor compound |
| 09/11/2007 | US7268110 Agents for preventing and treating thrombocytopenia |
| 09/11/2007 | US7268109 Method for reducing pain |
| 09/11/2007 | US7268108 Alpha-melanocyte stimulating hormone derivatives and cosmetic application thereof |
| 09/11/2007 | US7267980 Stabilizing solution for cells and tissues |
| 09/11/2007 | US7267973 Nucleic acids encoding recombinant proteins containing Shiga-like toxin and vascular endothelial growth factor |
| 09/11/2007 | US7267963 Modified plant viruses and methods of use thereof |
| 09/11/2007 | US7267940 HSV-2 type-specific immunoassays using glycoprotein G2 peptides |
| 09/11/2007 | US7267823 Administering to a mammal an immunogenic formulation containing an Ebola peptide, to induce a protective cytotoxic T lymphocyte response |
| 09/11/2007 | US7267822 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 09/11/2007 | US7267820 Detecting in body fluid an autoantibody to epitopes of muscle tyrosine kinase |
| 09/11/2007 | US7267819 Composition comprising and method of using angiopoietin-like protein 3 Angptl3 |
| 09/11/2007 | US7267817 Administering mixture of red blood cells and hemoglobin solution |
| 09/11/2007 | CA2359932C Treating protein-containing liquids |
| 09/11/2007 | CA2310536C Erythropoietin derivatives |
| 09/11/2007 | CA2275717C Chitosan-gelatin a microparticles |
| 09/11/2007 | CA2247040C Purification method |
| 09/11/2007 | CA2228138C The use of autologous dermal fibroblasts for the repair of skin and soft tissue defects |
| 09/11/2007 | CA2172963C Aspartoacylase gene, protein, and methods of screening for mutations associated with canavan disease |
| 09/11/2007 | CA2164498C Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
| 09/11/2007 | CA2151381C Recombinant dog gastric lipase and pharmaceutical compositions |
| 09/11/2007 | CA2124690C Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer |
| 09/11/2007 | CA2115355C Novel tetrapeptide derivative |
| 09/07/2007 | WO2007101005A2 Compositions and methods for effecting controlled posterior vitreous detachment |
| 09/07/2007 | WO2007100882A2 Tissue adhesives and sealants and methods for their use |
| 09/07/2007 | WO2007100795A2 Combinations comprising a histone deacetylase inhibiting agent and a nuclear hormone receptor ligand for treating cardiovascular conditions |
| 09/07/2007 | WO2007100745A2 Apparatus and formulations for suprachoroidal drug delivery |
| 09/07/2007 | WO2007100684A2 Extracellular matrix/metastasis modifer genes for the prevention or inhibition of metastasis or growth of tumor and for characterization of tumor |
| 09/07/2007 | WO2007100675A2 Collagenase for treating cellulite |
| 09/07/2007 | WO2007100568A2 T cell receptors and related materials and methods of use |
| 09/07/2007 | WO2007100535A2 Oxyntomodulin derivatives |
| 09/07/2007 | WO2007100465A2 Phosphatase inhibitor protein-1 as a regulator of cardiac function |
| 09/07/2007 | WO2007100385A2 Macrocyclic depsipeptide antibody-drug conjugates and methods |
| 09/07/2007 | WO2007100248A2 Adir related polymorphisms and applications thereof |
| 09/07/2007 | WO2007100098A1 Multimer of extracellular domain of cell surface functional molecule |
| 09/07/2007 | WO2007100071A1 Npy y4 agonist as therapeutic agent for disease accompanied by intestinal tract dysfunction |
| 09/07/2007 | WO2007099993A1 Antiviral peptide and antiviral agent |
| 09/07/2007 | WO2007099953A1 Tooth root formation promoter and method for promotion of tooth root formation |
| 09/07/2007 | WO2007099921A1 PEPTIDE BINGING TO PILRα, POLYNUCLEOTIDE ENCODING THE SAME AND APPLICATION THEREOF |
| 09/07/2007 | WO2007099660A1 Polymer micelle complex including nucleic acid |
| 09/07/2007 | WO2007099345A1 Medical use of bmp-2 and/ or bmp-4 |
| 09/07/2007 | WO2007099227A2 Use of the engrailed homeodomain protein as an anxiolytic |
| 09/07/2007 | WO2007099151A1 Methods and agents for reducing oxidative stress |
| 09/07/2007 | WO2007099145A1 G-csf liquid formulation |
| 09/07/2007 | WO2007098950A1 Master gene of arteriogenesis |
| 09/07/2007 | WO2007098719A1 Use of ck2 inhibitor for the treatment and chemosensibilization of refractory tumors to anticancer drugs |
| 09/07/2007 | WO2007098716A1 Compounds analogous to growth hormone peptide secretagogues and preparations containing them |
| 09/07/2007 | WO2007098715A1 Pharmaceutical composition containing ghrp-6 capable of preventing and eliminating fibrosis and other forms of pathological deposit in tissue |
| 09/07/2007 | WO2007098611A1 Compositions for treatment of cancer |
| 09/07/2007 | WO2007098607A1 Methods and compositions to treat and detect misfolded-sod1 mediated diseases |
| 09/07/2007 | WO2007098604A1 Preventing il-2 mediated inflammation in epithelial cells |
| 09/07/2007 | WO2007098588A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 09/07/2007 | WO2007098575A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |